Sort
141,003 grants matching “cytokine”
Genetic neuroscience: How human genes and alleles shape neuronal phenotypes
$4,132,864Steven Andrew McCarroll · Broad Institute, Inc. · U01 · FY2018 · MH
Genetic neuroscience: How human genes and alleles shape neuronal phenotypes
$4,129,117Steven Andrew McCarroll · Broad Institute, Inc. · U01 · FY2019 · MH
Genetic neuroscience: How human genes and alleles shape neuronal phenotypes
$4,125,261Steven Andrew McCarroll · Broad Institute, Inc. · U01 · FY2020 · MH
Obesity, Body Fat Distribution, and Cancer Risk in the Multiethnic Cohort
$4,121,831Loic Le Marchand · University Of Hawaii At Manoa · P01 · FY2015 · CA
Humanized Mouse Avatars for T1D
$4,109,951Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · UC4 · FY2014 · DK
Studies of Inherited Causes of Fungal Susceptability
$4,100,812Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Gene Expression and Regulatory Networks in Human Leukocytes
$4,097,745Christophe O Benoist · Harvard Medical School · RC2 · FY2009 · GM
Immunobiology of Peanut Allergy and Its Treatment: A Prototype
$4,097,659Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2008 · AI
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$4,095,914Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$4,095,431Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$4,078,100Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIC · FY2013 · HL
Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma
$4,070,979Thomas A Waldmann · Clinical Sciences · Z01 · FY2007 · CA
BAC Transgenic Mouse Models of TREM2 to Study Neuroprotective Mechanisms in AD
$4,060,769Xiangdong William Yang · University Of California Los Angeles · RF1 · FY2017 · AG
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$4,043,556Robert E Donahue · National Heart, Lung, And Blood Institute · ZIC · FY2018 · HL
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Lab
$4,039,864Michael Busch · Vitalant · N01 · FY2013 · HL
A fully humanized functional genomic screen to identify and validate pain therapeutic targets
$4,039,366Theodore J Price · University Of Texas Dallas · RF1 · FY2025 · NS
IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody
$4,026,705Matthew W Kalnik · Antidote Therapeutics, Inc. · U01 · FY2023 · DA
Genetic neuroscience: How human genes and alleles shape neuronal phenotypes
$4,026,586Steven Andrew McCarroll · Broad Institute, Inc. · U01 · FY2021 · MH
Advanced MRI FOR Uteroplacental Flow, Perfusion, Oxygenation & Inflammation
$4,023,484Dinesh Manilal Shah · University Of Wisconsin-Madison · U01 · FY2015 · HD
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$4,005,841Stacey Lynn Clardy · University Of Utah · U01 · FY2021 · NS
Microglial apoE in neuroinflammation and Alzheimer's disease
$4,000,570John David Fryer · Mayo Clinic Arizona · RF1 · FY2019 · AG
A Multi-Center Group to Study Acute Liver Failure in Children
$4,000,000Robert H Squires · University Of Pittsburgh At Pittsburgh · U01 · FY2014 · DK
From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects
$3,986,147Brian Jason Wainger · Massachusetts General Hospital · RM1 · FY2025 · NS
MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF PANDEMIC FLU
$3,972,316Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · P01 · FY2009 · AI
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,970,523Stacey Lynn Clardy · University Of Utah · U01 · FY2022 · NS